03.09.26 -- Expanding Influenza Study Access Via Community-Based Research

By operationalizing the early-phase strategies discussed in this article, trial teams can ensure that foundational safety and efficacy data are captured without the delays that derail studies.

By providing research sites with a unified, streamlined interface, we can reduce operational friction, enhance collaboration, and ultimately accelerate the development of new therapies.

The FDA encourages patient experience data in drug labeling but often excludes it for low rigor. New guidelines should help sponsors meet strict methodological standards.

By meeting participants where they are, this study sets a new benchmark for inclusive, efficient, and impactful vaccine development.

Alzheimer's trials face urgent recruitment challenges. Data-driven strategies, digital tools, and community engagement can accelerate enrollment and improve retention in this complex therapeutic space.

Whether used for routine appointments or trial participation, Lyft Pass ensures that patients have timely access to transportation, supporting adherence to schedules and improving overall engagement.